Sanctuary Advisors
CGON icon

Sanctuary Advisors’s CG Oncology CGON Stock Holding History

Sanctuary Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$427K Sell
6,007
-230
-4% -$15K ﹤0.01% 2088
2026
Q1 		$422K Buy
+6,237
New +$353K ﹤0.01% 1887

Other funds holding CGON

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sanctuary Advisors's CGON Position: Q2 2026 in Review

Sanctuary Advisors reduced its CG Oncology (CGON) stake by 3.7% in Q2 2026, selling an estimated $15K and leaving 6,007 shares worth $427K. The position accounts for ﹤0.01% of the portfolio, ranked #2088.

Sanctuary Advisors first reported a position in CGON in Q1 2026 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Sanctuary Advisors held 6,007 shares of CG Oncology worth $427K as of Q2 2026.
  • Sanctuary Advisors sold 230 CG Oncology shares in Q2 2026, an estimated $15K.
  • CG Oncology made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2088 holding.
  • Sanctuary Advisors first reported a position in CG Oncology in Q1 2026 and has held it in 2 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.